Vincerx Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.70 M | $1.94 M | 36.02% | 5.92% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 2.21 M | $1.58 M | -11.33% | 4.83% |
| SAGE RHINO CAPITAL LLC | 11/01/2024 | 1.70 M | $1.22 M | 0.00% | 3.73% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 891,719 | $638,471 | 0.00% | 1.95% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 674,193 | $482,722 | 0.00% | 1.48% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 631,424 | $452,100 | 0.00% | 1.38% |
| VANGUARD GROUP INC | 11/13/2024 | 627,442 | $449,248 | 0.00% | 1.37% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 542,021 | $388,000 | 13.40% | 1.19% |
| MARSHALL WACE, LLP | 11/14/2024 | 353,562 | $254,565 | 7.62% | 0.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 250,800 | $179,615 | 8.67% | 0.55% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 116,873 | $83,681 | 0.00% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 66,001 | $47,257 | -49.28% | 0.14% |
| STATE STREET CORP | 11/14/2024 | 57,016 | $40,823 | 0.00% | 0.12% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 47,080 | $33,709 | 100.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 31,980 | $22,898 | 100.00% | 0.07% |
| JANE STREET GROUP, LLC | 11/15/2024 | 20,905 | $14,968 | 100.00% | 0.05% |
| XTX TOPCO LTD | 11/14/2024 | 18,320 | $13,117 | 0.76% | 0.04% |
| HRT FINANCIAL LP | 11/12/2024 | 14,701 | $10,000 | 100.00% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 14,227 | $10,187 | -16.42% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 6,989 | $5,004 | -11.54% | 0.02% |
| MORGAN STANLEY | 11/14/2024 | 1,750 | $1,253 | 0.00% | 0.00% |
| BANK & TRUST CO | 10/09/2024 | 1,000 | $716 | 0.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 238 | $171 | 23,700.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 211 | $151 | 0.48% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 58 | $42 | 100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| COLONY GROUP, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| LMR PARTNERS LLP | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Vincerx Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Vincerx Pharma, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 2.7 M
Prosight Management, LP: 2.21 M
SAGE RHINO CAPITAL LLC: 1.7 M
Rock Springs Capital Management LP: 891,719
Point72 Asset Management, L.P.: 674,193
GOLDMAN SACHS GROUP INC: 631,424
24.12% of Vincerx Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 11.06 M shares in the last 24 months. This purchase volume represents approximately $2.32 M in transactions.